Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,462 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up.
Colleoni M, Sun Z, Martinelli G, Basser RL, Coates AS, Gelber RD, Green MD, Peccatori F, Cinieri S, Aebi S, Viale G, Price KN, Goldhirsch A; International Breast Cancer Study Group. Colleoni M, et al. Among authors: martinelli g. Ann Oncol. 2009 Aug;20(8):1344-51. doi: 10.1093/annonc/mdp024. Epub 2009 May 25. Ann Oncol. 2009. PMID: 19468030 Free PMC article. Clinical Trial.
Multicycle dose-intensive chemotherapy for women with high-risk primary breast cancer: results of International Breast Cancer Study Group Trial 15-95.
International Breast Cancer Study Group; Basser RL, O'Neill A, Martinelli G, Green MD, Peccatori F, Cinieri S, Coates AS, Gelber RD, Aebi S, Castiglione-Gertsch M, Viale G, Price KN, Goldhirsch A. International Breast Cancer Study Group, et al. Among authors: martinelli g. J Clin Oncol. 2006 Jan 20;24(3):370-8. doi: 10.1200/JCO.2005.03.5196. J Clin Oncol. 2006. PMID: 16421418 Clinical Trial.
Primary chemotherapy in operable breast cancer with favorable prognostic factors: a pilot study evaluating the efficacy of a regimen with a low subjective toxic burden containing vinorelbine, 5-fluorouracil and folinic acid (FLN).
Nolè F, Minchella I, Colleoni M, Orvieto E, Munzone E, de Braud F, Peruzzotti G, Martinelli G, Zampino MG, Catania C, Pizzamiglio M, Veronesi P, Zurrida S, Galimberti V, Goldhirsch A, Veronesi U. Nolè F, et al. Among authors: martinelli g. Ann Oncol. 1999 Aug;10(8):993-6. doi: 10.1023/a:1008389106575. Ann Oncol. 1999. PMID: 10509165 Free article. Clinical Trial.
High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel.
Crivellari D, Pagani O, Veronesi A, Lombardi D, Nolè F, Thürlimann B, Hess D, Borner M, Bauer J, Martinelli G, Graffeo R, Sessa C, Goldhirsch A; International Breast Cancer Study Group. Crivellari D, et al. Among authors: martinelli g. Ann Oncol. 2001 Mar;12(3):353-6. doi: 10.1023/a:1011132609055. Ann Oncol. 2001. PMID: 11332148 Free article. Clinical Trial.
Rituximab in lymphocyte-predominant Hodgkin disease.
Azim HA Jr, Pruneri G, Cocorocchio E, Cinieri S, Raviele PR, Bassi S, Preda L, Martinelli G, Peccatori FA. Azim HA Jr, et al. Among authors: martinelli g. Oncology. 2009;76(1):26-9. doi: 10.1159/000177953. Epub 2008 Nov 24. Oncology. 2009. PMID: 19033694
Chemotherapy during pregnancy: what is really safe?
Peccatori F, Martinelli G, Gentilini O, Goldhirsch A. Peccatori F, et al. Among authors: martinelli g. Lancet Oncol. 2004 Jul;5(7):398. doi: 10.1016/S1470-2045(04)01506-2. Lancet Oncol. 2004. PMID: 15231245 No abstract available.
1,462 results